We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Interaction of tankyrase and peroxiredoxin II is indispensable for the survival of colorectal cancer cells.
- Authors
Dong Hoon Kang; Doo Jae Lee; Sunmi Lee; So-Young Lee; Yukyung Jun; Yerin Kim; Youngeun Kim; Ju-Seog Lee; Dae-Kee Lee; Sanghyuk Lee; Eek-Hoon Jho; Dae-Yeul Yu; Sang Won Kang
- Abstract
Mammalian 2-Cys peroxiredoxin (Prx) enzymes are overexpressed in most cancer tissues, but their specific signaling role in cancer progression is poorly understood. Here we demonstrate that Prx type II (PrxII) plays a tumor-promoting role in colorectal cancer by interacting with a poly(ADP-ribose) polymerase (PARP) tankyrase. PrxII deletion in mice with inactivating mutation of adenomatous polyposis coli (APC) gene reduces intestinal adenomatous polyposis via Axin/β-catenin axis and thereby promotes survival. In human colorectal cancer cells with APC mutations, PrxII depletion consistently reduces the β-catenin levels and the expression of β-catenin target genes. Essentially, PrxII depletion hampers the PARP-dependent Axin1 degradation through tankyrase inactivation. Direct binding of PrxII to tankyrase ARC4/5 domains seems to be crucial for protecting tankyrase from oxidative inactivation. Furthermore, a chemical compound targeting PrxII inhibits the expansion of APC-mutant colorectal cancer cells in vitro and in vivo tumor xenografts. Collectively, this study reveals a redox mechanism for regulating tankyrase activity and implicates PrxII as a targetable antioxidant enzyme in APC-mutation-positive colorectal cancer.
- Publication
Nature Communications, 2017, Vol 8, Issue 6, p1
- ISSN
2041-1723
- Publication type
Article
- DOI
10.1038/s41467-017-00054-0